Somatostatin inhibits insulin and glucagon release by monolayer cell cultures of rat endocrine pancreas.
D000818:Animals; D000831:Animals, Newborn; D000941:Antigens; D001120:Arginine / Q000494:pharmacology; D001665:Binding Sites; D002478:Cells, Cultured; D046508:Culture Techniques; D003864:Depression, Chemical; D005934:Glucagon / Q000276:immunology / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors*; D007328:Insulin / Q000276:immunology / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology*; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin / Q000494:pharmacology; D013997:Time Factors
D000941:Antigens; D007328:Insulin; D010455:Peptides; D013004:Somatostatin; D005934:Glucagon; D013007:Growth Hormone-Releasing Hormone; D001120:Arginine